Yongqing Li

4.0k citations
131 papers · 3.2k indexed · h-index 33
Topics
Histone Deacetylase Inhibitors Research (22 papers)RNA Research and Splicing (21 papers)Genomics and Chromatin Dynamics (17 papers)

In The Last Decade

Yongqing Li

127 papers receiving 3.1k citations

Peers

Yongqing Li
Comparison fields: 5 of 124
  • Molecular Biology 2.0k
  • Plant Science 698
  • Immunology 404
  • Cancer Research 358
  • Oncology 299
Replace Alexandre Philips with:
Alexandre Philips France
Klaus Huse Germany
Issidora S. Papassideri Greece
Maeve O’Sullivan United States
Yufeng Tian United States
Helen M. Beere United States
Matthias Bauer Germany
Kyoko Toda Japan
Hideaki Fujita Japan
Yongqing Li relative to Alexandre Philips France Alexandre Philips's profile →
Citations per field
00.5×4.4×
Alexandre Philips · 1×
Citations per year

Countries citing papers authored by Yongqing Li

Since Specialization
Citations

This map shows the geographic impact of Yongqing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongqing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongqing Li more than expected).

Fields of papers citing papers by Yongqing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongqing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongqing Li. The network helps show where Yongqing Li may publish in the future.

Co-authorship network of co-authors of Yongqing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yongqing Li. A scholar is included among the top collaborators of Yongqing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongqing Li. Yongqing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 4
4 11
5 1
6 1
7 10
8 10
9 3
10 1
11 4
12 39
13 17
14 28
15 5
16
A Preparation of Polyclonal Antibody and Expression of Human CXXC5 Gene
1
17 39
18 58
19 20
20 27

About Yongqing Li

Yongqing Li is a scholar working on Molecular Biology, Cancer Research and Pharmacology, having authored 131 papers that have together received 3.2k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (22 papers), RNA Research and Splicing (21 papers) and Genomics and Chromatin Dynamics (17 papers). The work is most often cited by research in Molecular Biology (2.0k citations), Critical Care and Intensive Care Medicine (143 citations) and Cancer Research (358 citations). Yongqing Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Hasan B. Alam, Donald Küfe, Jian Hua, Jian Ren, Baoling Liu, Huijun Yang, George C. Velmahos, Yuequn Wang, Wuzhou Yuan and Marc DeMoya. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and PLANT PHYSIOLOGY.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026